# CAN SLIM Progress Board

Last updated: 2026-09-14

Frozen quantitative v1 remains research-complete but not production-ready. FWD1 and EXH2 continue unchanged. The theory-fidelity path now extends through #54. #43 remains the current stock-level lifecycle arbiter; #44 is climax/exhaustion evidence-only; #45/#46 form the portfolio-level CAN SLIM `M` state-to-exposure path; #47-#50 define and operate the major-index production path; #51 defines leadership/weakening evidence; #52 audits its source boundary; #53 prospectively archives broad-market membership; #54 now has a frozen Cycle 1 research selector, a frozen data-readiness gate, and live broad-market provider audits, but no production-authorized broad-market OHLCV panel or institutional-demand evidence.

## Repository boundary for #33

**Canonical #33 implementation and P8 morphology validation live in `azharmz/ussy-oneil-patterns`.** Frozen production contract: `oneil-pattern-output-v2` with only `FLAT_BASE`, `DOUBLE_BOTTOM`, `CUP_WITHOUT_HANDLE`, and `CUP_WITH_HANDLE`. P6 advanced patterns remain excluded and frozen.

## Theory Fidelity / v2 path

| # | Workstream | Status |
|---:|---|---|
| 25 | Theory Fidelity Audit | **COMPLETE** |
| 26 | Proper-base definitions | **COMPLETE** |
| 27 | Pivot / buy-point definition | **COMPLETE** |
| 28 | Breakout + volume confirmation | **COMPLETE** |
| 29 | RS / leadership fidelity | **COMPLETE** |
| 30 | C/A/S/I/M role fidelity | **COMPLETE** |
| 31 | Sell / risk-management fidelity | **COMPLETE** |
| 32 | Theory-faithful candidate specification | **COMPLETE / FROZEN v1** |
| 33 | O'Neil Pattern Recognition Engine | **CORE COMPLETE / FROZEN — P8 CONDITIONAL PASS** |
| 34 | Theory-faithful candidate generator | **COMPLETE / FROZEN v1** |
| 35 | New-candidate validation | **COMPLETE / FROZEN — CONDITIONAL PASS** |
| 36 | Execution / entry research | **BASELINE FROZEN / DIAGNOSTIC COMPLETE / PRIMARY PERFORMANCE VALIDATION BLOCKED_ON_ELIGIBLE_POPULATION** |
| 37 | Sell / risk execution semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 38 | Technical deterioration evidence | **EVIDENCE LAYER COMPLETE / FROZEN v1** |
| 39 | Weekly aggregation / 10-week evidence | **WEEKLY AGGREGATION + 10W EVIDENCE COMPLETE / FROZEN v1** |
| 40 | Technical deterioration action semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 41 | Position lifecycle / exit arbiter | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 42 | Round-trip sell action semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 43 | Position lifecycle / exit arbiter v2 | **IMPLEMENTATION COMPLETE / FROZEN v2** |
| 44 | Climax / exhaustion evidence | **EVIDENCE LAYER COMPLETE / FROZEN v1** |
| 45 | Market exposure action semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 46 | Market state evidence / classification | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 47 | Market input data contract | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 48 | Major index source audit | **SOURCE AUDIT COMPLETE — YAHOO/YFINANCE APPROVED FOR INITIAL PRODUCTION INPUT v1** |
| 49 | Production market index publisher | **PRODUCTION WIRING COMPLETE / LIVE v1** |
| 50 | Production market-state consumer | **PRODUCTION CONSUMER COMPLETE / LIVE v1** |
| 51 | Market leadership / weakening evidence | **EVIDENCE CONTRACT COMPLETE / PRODUCTION BOOLEAN SOURCE DEFERRED** |
| 52 | PIT broad-market leadership source audit | **SOURCE AUDIT COMPLETE / NO PRODUCTION BOOLEAN SOURCE APPROVED** |
| 53 | Prospective broad-market membership publisher | **PRODUCTION MEMBERSHIP ARCHIVE LIVE / LEADERSHIP BOOLEAN STILL DEFERRED** |
| 54 | PIT leader-cohort / institutional-demand evidence study | **CYCLE 1 SEMANTIC BASELINE FROZEN / BROAD-MARKET OHLCV SOURCE STACK INCOMPLETE / NOT PRODUCTION AUTHORIZED** |

## Current canonical architecture

```text
STOCK
#33 Pattern → #34 Candidate → #35 Validation → #36 Entry
→ OPEN POSITION
→ #37 Capital Protection / #40 Technical Deterioration / #42 Round-Trip
→ #43 Stock Lifecycle Arbiter → CLOSED POSITION

#44 Climax/Exhaustion = evidence sidecar only

GENERAL MARKET / CAN SLIM M
#49 production major-index data
→ #50 production consumer → frozen #46 Market State Classification
↑
#51 Leadership / Weakening Evidence contract
↑
#52 source audit
↑
#53 prospective broad-market membership archive
→ #54 Cycle 1 research leader candidate selector
→ [broad-market stock OHLCV source stack incomplete]
→ [institutional-demand source still unresolved]
→ #45 Portfolio Exposure Action once evidence is complete
```

## Key frozen validation state

#34 final verification `34758050282` → **SUCCESS, 9 tests**. #35 canonical historical run `34763920536` produced 265,642 observations with zero V35-A/B/C findings and a frozen 60-case corpus. Independent source-evidence audit `34765922653` → **SUCCESS**, C/A/L/M 60/60 MATCH and PIT violations = 0. #35 remains `CONDITIONAL PASS` solely with upstream #33 morphology debt preserved.

#36 canonical T+1-open execution remains frozen; primary performance validation remains `BLOCKED_ON_ELIGIBLE_POPULATION` because canonical #35 has 0 `CANSLIM_ELIGIBLE` observations.

#37 capital protection, #40 technical deterioration and #42 round-trip are the three frozen executable stock-level exit channels. #43 v2 arbitrates them by earliest causal executable exit. Canonical validations remain green: #36 `34785545504`; #37 `34787905360`; #38 `34788119495`; #39 `34788414986`; #40 `34789559782`; #41 `34790106465`; #42 `34793348883`; #43 `34796938374`.

#44 contract `44-climax-exhaustion-evidence-v1` remains evidence-only. Canonical run `34797449482` → **SUCCESS, 10 passed**.

#45 contract `45-market-exposure-action-v1` remains frozen. Canonical run `34802432732` / job `103847631050` → **SUCCESS, 12 passed**.

#46 contract `46-market-state-classification-v1` remains frozen. Canonical run `34803676270` / job `103851194650` → **SUCCESS, 13 passed**.

#47 contract `47-market-input-data-contract-v1` freezes `NASDAQ_COMPOSITE`, `SP500`, and `DJIA`; SPY/QQQ/DIA are not substitutes. Run `34806193999` / job `103858438691` → **SUCCESS**.

## #48–#50 — Major-index production path

#48 approved Yahoo/yfinance for initial production input v1 for `^IXIC`, `^GSPC`, and `^DJI` after reproducible source audit. #49 publishes immutable major-index run objects and advances `market/indexes/official.json` only after complete publication; first live run `34808006835` succeeded. #50 verifies the pointer, manifest/object SHA-256 lineage and frozen #47 identity contract, then imports frozen #46. First live run `34809438828` produced `FOLLOW_THROUGH_CONFIRMED` as of 2026-09-11.

Because leadership/weakening booleans remain unresolved, #50 must not promote the state to `UPTREND_HEALTHY` or `UPTREND_WEAKENING` from fabricated evidence.

## #51–#53 — Leadership evidence prerequisites

#51 freezes acceptable leadership/weakening evidence and keeps missing channels tri-state. #52 concludes no current source stack satisfies every production gate. #53 is live in `azharmz/ussy-data` and prospectively archives Nasdaq Trader `nasdaqlisted.txt` and `otherlisted.txt` into immutable R2 runs with raw files, normalized membership, digests, timestamps and an official pointer. First live #53 run `34823149519` / job `103909085792` succeeded.

The current USSY/Musaffa universe remains prohibited as a proxy for broad-U.S.-market leadership.

## #54 — PIT Leader-Cohort / Institutional-Demand Evidence Study

Study `54-pit-leader-cohort-institutional-demand-study-v1` freezes the admissible evidence families upstream of #51. Its base semantic packet remains validated by run `34823754541` / job `103911008100` → **SUCCESS, 8 tests**.

### Experimental Cycle 1 selector

Preregistered selector `54-cycle1-candidate-leader-selector-v1` freezes a research-only candidate cohort:

- PIT #53 broad-market membership;
- ETF/test issues excluded;
- 252 completed adjusted-close observations;
- canonical `SP500` benchmark;
- transparent project 252-session relative-return percentile >= 80;
- current adjusted close >= 90% of trailing 252-session adjusted-close high.

The 80 percentile and 10%-from-high anchors come from O'Neil/AAII screening guidance. The 252-session calculation and upper empirical-CDF percentile are explicit project research conventions and are not represented as proprietary IBD RS Rating semantics.

Canonical Cycle 1 semantic run `34828024938` / job `103924556850` → **SUCCESS, 11 tests**. The first attempt failed only because a synthetic boundary fixture did not contain the intended exact high; the fixture was corrected without changing selector semantics.

Cycle 1 can emit only `LEADER_CANDIDATE`, `NOT_LEADER_CANDIDATE`, or `NOT_EVALUABLE`. It cannot emit #51 production booleans because PIT institutional-demand/selling evidence remains unresolved.

### Cycle 1 data readiness

A separate data-readiness gate confirmed that the existing `ussy-data` rolling stock panel is restricted to the confirmed compliant USSY/Musaffa universe and therefore cannot serve as the broad-market RS cross-section required by #54.

Canonical readiness run `34846025920` / job `103982067238` → **SUCCESS**.

Verdict: **BLOCKED_ON_BROAD_MARKET_OHLCV / SELECTOR NOT EXECUTED**.

### Broad-market OHLCV provider audits

Two read-only audits were run against the same live #53 membership run `34823149519`, using a deterministic 100-symbol sample from 7,504 non-ETF/non-test symbols and requiring >=252 adjusted-close observations.

**Tiingo-only audit** — run `34847652001` / job `103987413383` → **SUCCESS**. The report recorded 68 successful responses, 32 errors, and 56/100 sampled symbols with >=252 adjusted-close observations. Artifact `10348671364`, ZIP SHA-256 `97ba227b22459d2f0b538a0e0f907ceb7a41cc3c271a36108362ec37477bf427`.

**Tiingo → Yahoo/yfinance provider-stack audit** — run `34848036669` / job `103988656423` → **SUCCESS, 7 tests**. The stack resolved 72/100 sampled symbols with >=252 adjusted-close observations and left 28 unresolved. In that run all 72 selected observations came through Yahoo/yfinance fallback and zero were selected from Tiingo.

The difference between the Tiingo-only report (56 symbols with >=252 bars) and the provider-stack report (zero Tiingo selections) is preserved as an unresolved source-audit inconsistency; it must be investigated rather than silently reconciled.

The unresolved sample visibly includes preferred/share-class, warrant and right-like symbol forms. Cycle 1 currently excludes only ETFs and test issues, so those instruments cannot be silently removed after seeing provider failures.

Current #54 terminal status: **CYCLE 1 SEMANTIC BASELINE FROZEN / BROAD-MARKET OHLCV SOURCE STACK INCOMPLETE / NOT PRODUCTION AUTHORIZED**.

## Forward / production boundaries

FWD1 remains LIVE / ACCUMULATING with its existing gate; EXH2 remains separate and prospective. Theory-fidelity findings must not be retrofitted into FWD1/X3/EXH2.

## Active work from here

1. Keep frozen contracts and Cycle 1 semantics frozen; do not retune thresholds from returns.
2. Primary lifecycle/performance validation remains blocked until a genuine frozen `CANSLIM_ELIGIBLE` population exists.
3. Allow #53 to accumulate prospective immutable membership history; never backfill old membership using a later snapshot.
4. Inside #54, perform a preregistered **security-type / provider-symbol identity audit** before authorizing any broad-market OHLCV publisher. Resolve the Tiingo audit inconsistency explicitly.
5. Do not compute broad-market RS percentiles from a provider-availability subset or from the restricted USSY/Musaffa rolling universe.
6. Continue auditing a permitted PIT institutional-demand/selling source; candidate cohort alone is insufficient for #51.
7. Until an approved selector + data + demand source stack exists, #50 continues passing `leadership_confirming=None` and `weakening_confirmed=None`.
8. A future production exposure consumer may publish frozen #45 E0–E4 state after the market-state evidence path is complete.
9. Preserve #33 morphology debt, keep P6 out of production, and keep FWD1/EXH2 unchanged.
